-+ 0.00%
-+ 0.00%
-+ 0.00%

Monte Rosa Therapeutics Q3 Sales $12.768M Beat $5.420M Estimate

Benzinga·11/06/2025 12:24:07
Listen to the news
Monte Rosa Therapeutics (NASDAQ:GLUE) reported quarterly sales of $12.768 million which beat the analyst consensus estimate of $5.420 million by 135.57 percent. This is a 38.54 percent increase over sales of $9.216 million the same period last year.